BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 24757116)

  • 1. Cognition in corticobasal syndrome and progressive supranuclear palsy: a review.
    Burrell JR; Hodges JR; Rowe JB
    Mov Disord; 2014 Apr; 29(5):684-93. PubMed ID: 24757116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased tau burden in the cortices of progressive supranuclear palsy presenting with corticobasal syndrome.
    Tsuboi Y; Josephs KA; Boeve BF; Litvan I; Caselli RJ; Caviness JN; Uitti RJ; Bott AD; Dickson DW
    Mov Disord; 2005 Aug; 20(8):982-8. PubMed ID: 15834857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diffusion-weighted brain imaging study of patients with clinical diagnosis of corticobasal degeneration, progressive supranuclear palsy and Parkinson's disease.
    Rizzo G; Martinelli P; Manners D; Scaglione C; Tonon C; Cortelli P; Malucelli E; Capellari S; Testa C; Parchi P; Montagna P; Barbiroli B; Lodi R
    Brain; 2008 Oct; 131(Pt 10):2690-700. PubMed ID: 18819991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severity dependent distribution of impairments in PSP and CBS: Interactive visualizations.
    Brittain C; McCarthy A; Irizarry MC; McDermott D; Biglan K; Höglinger GU; Lorenzl S; Del Ser T; Boxer AL; ; ; ;
    Parkinsonism Relat Disord; 2019 Mar; 60():138-145. PubMed ID: 30201421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sleep disturbances in progressive supranuclear palsy syndrome (PSPS) and corticobasal syndrome (CBS).
    Alster P; Madetko-Alster N; Migda A; Migda B; Kutyłowski M; Królicki L; Friedman A
    Neurol Neurochir Pol; 2023; 57(3):229-234. PubMed ID: 36928793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of progressive supranuclear palsy presenting with corticobasal syndrome: a cortical variant.
    Ling H; de Silva R; Massey LA; Courtney R; Hondhamuni G; Bajaj N; Lowe J; Holton JL; Lees A; Revesz T
    Neuropathol Appl Neurobiol; 2014 Feb; 40(2):149-63. PubMed ID: 23432126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Progressive Supranuclear Palsy: Past and Present Aspects.
    Parthimos TP; Schulpis KH
    Clin Gerontol; 2020; 43(2):155-180. PubMed ID: 31752626
    [No Abstract]   [Full Text] [Related]  

  • 8. PET Tau Imaging and Motor Impairments Differ Between Corticobasal Syndrome and Progressive Supranuclear Palsy With and Without Alzheimer's Disease Biomarkers.
    Vasilevskaya A; Taghdiri F; Multani N; Anor C; Misquitta K; Houle S; Burke C; Tang-Wai D; Lang AE; Fox S; Slow E; Rusjan P; Tartaglia MC
    Front Neurol; 2020; 11():574. PubMed ID: 32754109
    [No Abstract]   [Full Text] [Related]  

  • 9. The prevalence and incidence of progressive supranuclear palsy and corticobasal syndrome: a systematic review and meta-analysis.
    Lyons S; Trépel D; Lynch T; Walsh R; O'Dowd S
    J Neurol; 2023 Sep; 270(9):4451-4465. PubMed ID: 37289323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Caregiver strain in progressive supranuclear palsy and corticobasal syndromes.
    Kellermair L; Fuchs A; Eggers C; Schwingenschuh P; Kögl M; Fellner F; Forstner T; Mangesius S; Guger M; Ransmayr G
    J Neural Transm (Vienna); 2021 Oct; 128(10):1611-1621. PubMed ID: 34296340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progressive Supranuclear Palsy and Corticobasal Degeneration.
    Coughlin DG; Dickson DW; Josephs KA; Litvan I
    Adv Exp Med Biol; 2021; 1281():151-176. PubMed ID: 33433875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progressive Supranuclear Palsy and Corticobasal Syndrome.
    Pantelyat A
    Continuum (Minneap Minn); 2022 Oct; 28(5):1364-1378. PubMed ID: 36222770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative cognitive and neuropsychiatric profiles between Parkinson's disease, multiple system atrophy and progressive supranuclear palsy.
    Santangelo G; Cuoco S; Pellecchia MT; Erro R; Barone P; Picillo M
    J Neurol; 2018 Nov; 265(11):2602-2613. PubMed ID: 30178175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behavior and cognition in corticobasal degeneration and progressive supranuclear palsy.
    Kertesz A; McMonagle P
    J Neurol Sci; 2010 Feb; 289(1-2):138-43. PubMed ID: 19733862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence and Trends of Progressive Supranuclear Palsy and Corticobasal Syndrome: A Population-Based Study.
    Stang CD; Turcano P; Mielke MM; Josephs KA; Bower JH; Ahlskog JE; Boeve BF; Martin PR; Upadhyaya SG; Savica R
    J Parkinsons Dis; 2020; 10(1):179-184. PubMed ID: 31594251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Which ante mortem clinical features predict progressive supranuclear palsy pathology?
    Respondek G; Kurz C; Arzberger T; Compta Y; Englund E; Ferguson LW; Gelpi E; Giese A; Irwin DJ; Meissner WG; Nilsson C; Pantelyat A; Rajput A; van Swieten JC; Troakes C; Josephs KA; Lang AE; Mollenhauer B; Müller U; Whitwell JL; Antonini A; Bhatia KP; Bordelon Y; Corvol JC; Colosimo C; Dodel R; Grossman M; Kassubek J; Krismer F; Levin J; Lorenzl S; Morris H; Nestor P; Oertel WH; Rabinovici GD; Rowe JB; van Eimeren T; Wenning GK; Boxer A; Golbe LI; Litvan I; Stamelou M; Höglinger GU;
    Mov Disord; 2017 Jul; 32(7):995-1005. PubMed ID: 28500752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are frontotemporal lobar degeneration, progressive supranuclear palsy and corticobasal degeneration distinct diseases?
    Sha S; Hou C; Viskontas IV; Miller BL
    Nat Clin Pract Neurol; 2006 Dec; 2(12):658-65. PubMed ID: 17117169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does corticobasal degeneration exist? A clinicopathological re-evaluation.
    Ling H; O'Sullivan SS; Holton JL; Revesz T; Massey LA; Williams DR; Paviour DC; Lees AJ
    Brain; 2010 Jul; 133(Pt 7):2045-57. PubMed ID: 20584946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Managing cognition in progressive supranuclear palsy.
    Rittman T; Coyle-Gilchrist IT; Rowe JB
    Neurodegener Dis Manag; 2016 Dec; 6(6):499-508. PubMed ID: 27879155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Features of Patients With Nonfluent/Agrammatic Primary Progressive Aphasia With Underlying Progressive Supranuclear Palsy Pathology or Corticobasal Degeneration.
    Santos-Santos MA; Mandelli ML; Binney RJ; Ogar J; Wilson SM; Henry ML; Hubbard HI; Meese M; Attygalle S; Rosenberg L; Pakvasa M; Trojanowski JQ; Grinberg LT; Rosen H; Boxer AL; Miller BL; Seeley WW; Gorno-Tempini ML
    JAMA Neurol; 2016 Jun; 73(6):733-42. PubMed ID: 27111692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.